Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)-RFA-IP-23-002, Understanding Adult Immunization Quality Improvement Approaches Among Adult HCP and Health Departments; and RFA-IP-23-003, Programmatic Interventions To Increase Uptake of Influenza and COVID-19 Vaccination Among Students Attending Institutions of Higher Education; Amended Notice of Meeting, 5882 [2023-01800]

Download as PDF 5882 Federal Register / Vol. 88, No. 19 / Monday, January 30, 2023 / Notices Board of Governors of the Federal Reserve System. Margaret McCloskey Shanks, Deputy Secretary of the Board. [FR Doc. 2023–01851 Filed 1–27–23; 8:45 am] BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. Centers for Disease Control and Prevention [FR Doc. 2023–01800 Filed 1–27–23; 8:45 am] lotter on DSK11XQN23PROD with NOTICES1 Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)–RFA–IP–23– 002, Understanding Adult Immunization Quality Improvement Approaches Among Adult HCP and Health Departments; and RFA–IP–23– 003, Programmatic Interventions To Increase Uptake of Influenza and COVID–19 Vaccination Among Students Attending Institutions of Higher Education; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—RFA– IP–23–002, Understanding Adult Immunization Quality Improvement Approaches Among Adult HCP and Health Departments; and RFA–IP–23– 003, Programmatic Interventions To Increase Uptake of Influenza and COVID–19 Vaccination Among Students Attending Institutions of Higher Education; March 29–30, 2023, 10 a.m.– 5 p.m. EDT, Teleconference, Centers for Disease Control and Prevention, Room 1080, 8 Corporate Boulevard, Atlanta, Georgia, 30329, in the original FRN. The meeting was published in the Federal Register on December 23, 2022, Volume 87, Number 246, pages/s/78968–78969. The meeting is being amended to remove the second day of the meeting and should read as follows: Date: March 29, 2023. Time: 10 a.m.–5 p.m. (EDT). Place: Teleconference, Centers for Disease Control and Prevention, Room 1077, 8 Corporate Blvd., Atlanta, GA 30329. The meeting is closed to the public. FOR FURTHER INFORMATION CONTACT: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, National Center for HIV, Viral Hepatitis, STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8–1, Atlanta, Georgia 30329–4027; Telephone: (404) 718–8833; Email: GAnderson@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease VerDate Sep<11>2014 17:30 Jan 27, 2023 Jkt 259001 Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention National Center for Health Statistics (NCHS), ICD–10 Coordination and Maintenance (C&M) Committee Meeting Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: The CDC, National Center for Health Statistics (NCHS), Classifications and Public Health Data Standards Staff, announces the following meeting of the ICD–10 Coordination and Maintenance (C&M) Committee. This meeting is open to the public, limited only by the number of audio lines available. Online registration is required. DATES: The meeting will be held on March 7, 2023, from 9 a.m. to 5 p.m., EST, and March 8, 2023, from 9 a.m. to 5 p.m., EST. ADDRESSES: This is a virtual meeting. Register in advance at https:// cms.zoomgov.com/webinar/register/ WN__piUmNYaRjmkcYczb3ePIQ. After registering, you will receive a confirmation email containing information about joining the meeting. Further information will be provided on each of the respective web pages when it becomes available. For the Centers for Disease Control and Prevention, National Center for Health Statistics: https://www.cdc.gov/nchs/icd/icd10cm_ maintenance.htm. For the Centers for Medicare & Medicaid Services, Department of Health and Human Services: https://www.cms.gov/ Medicare/Coding/ICD10/C-and-MMeeting-Materials. FOR FURTHER INFORMATION CONTACT: Traci Ramirez, Medical Systems Specialist, National Center for Health Statistics, CDC, 3311 Toledo Road, Hyattsville, Maryland 20782–2064; SUMMARY: PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 Telephone: (301) 458–4454; Email: TRamirez@cdc.gov. SUPPLEMENTARY INFORMATION: Purpose: The ICD–10 Coordination and Maintenance (C&M) Committee is a public forum for the presentation of proposed modifications to the International Classification of Diseases, Tenth Revision, Clinical Modification (CM) and ICD–10 Procedure Coding System (PCS). Matters To Be Considered: The tentative agenda will include discussions on the ICD–10–CM and ICD–10–PCS topics listed below. Agenda items are subject to change as priorities dictate. Please refer to the posted agenda for updates one month prior to the meeting. ICD–10–PCS Topics 1. Administration of Elranatamab * 2. Administration of Epcoritamab * 3. Administration of Glofitamab * 4. Administration of Pafolacianine * 5. Administration of Posoleucel ** 6. Administration of Quizartinib * 7. Administration of Rezafungin * 8. Administration of SER–109 * 9. Administration of SulbactamDurlobactam * 10. Implantation of Bioprosthetic Femoral Venous Valves 11. Rapid Antimicrobial Susceptibility Testing of Blood Cultures * 12. Dual-Chamber Leadless Cardiac Pacemaker * 13. Percutaneous Femoral-Popliteal Artery Bypass * 14. Insertion of Lengthening Device for Esophageal Atresia 15. Implantation of Extraluminal Saphenous Vein Graft Support Device During Coronary Artery Bypass Graft (CABG) * 16. Short-term External Heart Assist with Graft 17. Ultrasound Ablation of Renal Sympathetic Nerves * 18. Computer-aided Detection of Heart Failure in Echocardiography * 19. Percutaneous Mechanical Circulatory Support 20. Monitoring of Intracranial Electrical Activity for Status Epilepticus * 21. Monitoring of Intracranial Electrical Activity for Delirium * 22. Rapid Antimicrobial Susceptibility Testing System for Blood and Body Fluid Cultures * 23. Percutaneous Hepatic Perfusion with Administration of Melphalan Hydrochloride ** 24. Insertion of Muscle Compartment Pressure Monitor * 25. Insertion of Tibial Extension Implant During Total Knee Arthroplasty * 26. Talar Replacement of Ankle * 27. Ankle Fusion with Truss Implant * E:\FR\FM\30JAN1.SGM 30JAN1

Agencies

[Federal Register Volume 88, Number 19 (Monday, January 30, 2023)]
[Notices]
[Page 5882]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-01800]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP)-RFA-IP-23-002, Understanding Adult Immunization 
Quality Improvement Approaches Among Adult HCP and Health Departments; 
and RFA-IP-23-003, Programmatic Interventions To Increase Uptake of 
Influenza and COVID-19 Vaccination Among Students Attending 
Institutions of Higher Education; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Disease, 
Disability, and Injury Prevention and Control Special Emphasis Panel 
(SEP)--RFA-IP-23-002, Understanding Adult Immunization Quality 
Improvement Approaches Among Adult HCP and Health Departments; and RFA-
IP-23-003, Programmatic Interventions To Increase Uptake of Influenza 
and COVID-19 Vaccination Among Students Attending Institutions of 
Higher Education; March 29-30, 2023, 10 a.m.-5 p.m. EDT, 
Teleconference, Centers for Disease Control and Prevention, Room 1080, 
8 Corporate Boulevard, Atlanta, Georgia, 30329, in the original FRN. 
The meeting was published in the Federal Register on December 23, 2022, 
Volume 87, Number 246, pages/s/78968-78969.
    The meeting is being amended to remove the second day of the 
meeting and should read as follows:
    Date: March 29, 2023.
    Time: 10 a.m.-5 p.m. (EDT).
    Place: Teleconference, Centers for Disease Control and Prevention, 
Room 1077, 8 Corporate Blvd., Atlanta, GA 30329.
    The meeting is closed to the public.

For Further Information Contact: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, National Center for HIV, Viral Hepatitis, 
STD, and TB Prevention, CDC, 1600 Clifton Road NE, Mailstop US8-1, 
Atlanta, Georgia 30329-4027; Telephone: (404) 718-8833; Email: 
[email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-01800 Filed 1-27-23; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.